Triflusal
CAS No. 322-79-2
Triflusal ( Triflusal, Disgren, Grendis, Aflen, Triflux )
产品货号. M14050 CAS No. 322-79-2
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥316 | 有现货 |
|
10MG | ¥518 | 有现货 |
|
25MG | ¥956 | 有现货 |
|
50MG | ¥1596 | 有现货 |
|
100MG | ¥2657 | 有现货 |
|
200MG | ¥3993 | 有现货 |
|
500MG | ¥6391 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Triflusal
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
-
产品描述Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
-
同义词Triflusal, Disgren, Grendis, Aflen, Triflux
-
通路Angiogenesis
-
靶点PDE
-
受体PDE; TXA2R
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number322-79-2
-
分子量248.16
-
分子式C10H7F3O4
-
纯度>98%(HPLC)
-
溶解度Ethanol: 50 mg/mL (201.48 mM); DMSO: 50 mg/mL (201.48 mM)
-
SMILESO=C(O)C1=CC=C(C(F)(F)F)C=C1OC(C)=O
-
化学全称2-acetyloxy-4-(trifluoromethyl)benzoic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Acta Crystallographica Section A, 49 ( Pt 1), 10-22 (1993)
产品手册
关联产品
-
Nortadalafil
Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
-
Zomepirac Sodium
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
-
Sildenafil citrate
Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).